Terms ending in 2026
Every in-force patent on Dexcom, Inc.'s record whose computed term ends in 2026, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,016,648 | Transcutaneous Analyte Sensor In force · High confidence | Dexcom, Inc. | In force | High confidence | |
| US 7,775,975 | Analyte Sensor In force · High confidence | Dexcom, Inc. | In force | High confidence | |
| US 8,298,142 | Analyte Sensor In force · High confidence | Dexcom, Inc. | In force | High confidence | |
| US 8,423,113 | Systems and Methods for Processing Sensor Data In force · High confidence | Dexcom, Inc. | In force | High confidence | |
| US 9,220,449 | System and Methods for Processing Analyte Sensor Data for Sensor Calibration In force · High confidence | Dexcom, Inc. | In force | High confidence | |
| US 12,397,110 | Integrated Insulin Delivery System with Continuous Glucose Sensor In force · High confidence | Dexcom, Inc. | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.